Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CARGO Therapeutics, Inc. (CRGX : NSDQ)

• Company Description    CARGO Therapeutics Inc. is a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022 and CRG-023. CARGO Therapeutics Inc. is based in San Mateo, California. Number of Employees: 167

• Price / Volume Information    Yesterday's Closing Price: $4.60 Daily Weekly Monthly 20 Day Moving Average: 1,832,693 shares Shares Outstanding: 46.11 (millions) Market Capitalization: $212.11 (millions) Beta: 0.28 52 Week High: $25.45 52 Week Low: $3.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.68% -1.17% 12 Week -0.86% -16.61% Year To Date -68.10% -70.13%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 835 Industrial Road Suite 400 - San Carlos,CA 94070 USA ph: 650-499-8950 fax: - ir@cargo-tx.com http://www.cargo-tx.com

• General Corporate Information    Officers Gina Chapman - Chief Executive Officer and Director John Orwin - Chairperson Anup Radhakrishnan - Chief Operating Officer and Chief Financial Office Abraham Bassan - Director Reid Huber - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 14179K101 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/11/25 Share - Related Items Shares Outstanding: 46.11 Most Recent Split Date: (:1) Beta: 0.28 Market Capitalization: $212.11 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.37 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.04 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.75 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 8.05% vs. Previous Quarter: 15.79% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -45.93 12/31/24 - -42.66 ROA 06/30/25 - - 03/31/25 - -39.58 12/31/24 - -37.69 Current Ratio 06/30/25 - - 03/31/25 - 6.30 12/31/24 - 13.79 Quick Ratio 06/30/25 - - 03/31/25 - 6.30 12/31/24 - 13.79 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 6.13 12/31/24 - 7.83 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©